(IBDR) iBonds Dec 2026 Term - Overview
Exchange: NYSE ARCA •
Country: USA •
Currency: USD •
Type: Etf •
ISIN: US46435GAA04
Etf: Bonds, Corporate, Investment Grade
Total Rating 39
Risk 74
Buy Signal 0.00
| Risk 5d forecast | |
|---|---|
| Volatility | 0.75% |
| Relative Tail Risk | -4.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 0.16 |
| Character TTM | |
|---|---|
| Beta | 0.017 |
| Beta Downside | -0.012 |
| Drawdowns 3y | |
|---|---|
| Max DD | 1.68% |
| CAGR/Max DD | 3.22 |
Description: IBDR iBonds Dec 2026 Term March 05, 2026
IBDR is an ETF that primarily invests in U.S. dollar-denominated, investment-grade corporate bonds. These bonds are issued by both U.S. and international companies.
The fund focuses on fixed-income securities with a target maturity of December 2026. Investment-grade corporate bonds are generally considered less risky than high-yield bonds, offering a balance of income and capital preservation.
Constituent bonds must have an outstanding face value of at least $300 million at the time of inclusion. This threshold typically ensures liquidity within the corporate bond market.
For more detailed analysis, consider exploring ValueRay.
Headlines to watch out for
- Corporate bond yields dictate funds income
- Interest rate changes impact bond valuations
- Credit rating downgrades increase default risk
- Economic recession elevates corporate default rates
What is the price of IBDR shares?
As of March 11, 2026, the stock is trading at USD 24.21 with a total of 607,142 shares traded.
Over the past week, the price has changed by +0.08%, over one month by +0.21%, over three months by +0.96% and over the past year by +4.54%.
Over the past week, the price has changed by +0.08%, over one month by +0.21%, over three months by +0.96% and over the past year by +4.54%.
Is IBDR a buy, sell or hold?
iBonds Dec 2026 Term has no consensus analysts rating.
What are the forecasts/targets for the IBDR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |